The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model

Reproductive Sciences

Volumn 22, Issue 9, 2015, Pages 1143-1152

  Quattrone, Federica ^a   Sanchez, Ana Maria ^a   Pannese, Maria ^a   Hemmerle, Teresa ^b   Viganò, Paola ^a   Candiani, Massimo ^a   Petraglia, Felice ^c   Neri, Dario ^b   Panina Bordignon, Paola ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

endometriosis; IL 4; immunocytokine

Indexed keywords

BETA CATENIN; GELATINASE B; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PEROXIDASE; STROMELYSIN; SURVIVIN; TETRAVIL; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VASCULOTROPIN; ANTIBODY CONJUGATE; AUTACOID; CADHERIN; CTNNB1 PROTEIN, MOUSE; CYTOKINE; F8 MONOCLONAL ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN VARIABLE REGION; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; ENDOMETRIOSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERUS; VASCULARIZATION; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CELL PROTECTION; DISEASE MODEL; DRUG EFFECTS; ENDOMETRIUM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; INTRAVENOUS DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHARMACOLOGY; TIME FACTOR;

ANIMALS; ANTIBODIES, MONOCLONAL; BETA CATENIN; CADHERINS; CELL ADHESION; CELL MOVEMENT; CHEMISTRY, PHARMACEUTICAL; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; GENE EXPRESSION REGULATION; IMMUNOCONJUGATES; IMMUNOGLOBULIN VARIABLE REGION; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-4; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; TIME FACTORS;

EID: 84939183835     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719115578930     Document Type: Article

References (47)

1. Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D'Hooghe T,. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2009; 92 (1): 68-74.
2. Bulun SE,. Endometriosis. N Engl J Med. 2009; 360 (3): 268-279.
3. Burney RO, Giudice LC,. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012; 98 (3): 511-519.
4. Tseng JF, Ryan IP, Milam TD,. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab. 1996; 81 (3): 1118-1122.
5. Wu Y, Kajdacsy-Balla A, Strawn E,. Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology. 2006; 147 (1): 232-246.
6. Sharpe-Timms KL, Cox KE,. Paracrine regulation of matrix metalloproteinase expression in endometriosis. Ann N Y Acad Sci. 2002; 955: 147-156; discussion 157-148, 396-406.
7. Akoum A, Jolicoeur C, Boucher A,. Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab. 2000; 85 (2): 896-904.
8. Nair AS, Nair HB, Lucidi RS,. Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription. Fertil Steril. 2008; 90 (4 suppl): 1487-1495.
9. May KE, Villar J, Kirtley S, Kennedy SH, Becker CM,. Endometrial alterations in endometriosis: a systematic review of putative biomarkers. Hum Reprod Update. 2011; 17 (5): 637-653.
10. Edwards AK, Nakamura DS, Virani S, Wessels JM, Tayade C,. Animal models for anti-angiogenic therapy in endometriosis. J Reprod Immunol. 2013; 97 (1): 85-94.
11. Lebovic DI, Mueller MD, Taylor RN,. Immunobiology of endometriosis. Fertil Steril. 2001; 75 (1): 1-10.
12. Bacci M, Capobianco A, Monno A,. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol. 2009; 175 (2): 547-556.
13. Capobianco A, Rovere-Querini P,. Endometriosis, a disease of the macrophage. Front Immunol. 2013; 4: 9.
14. Mariani M, Vigano P, Gentilini D,. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod. 2012; 27 (7): 2010-2019.
15. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P,. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod. 1999; 14 (12): 2944-2950.
16. Vercellini P, Vigano P, Somigliana E, Fedele L,. Endometriosis: pathogenesis and treatment. Nature reviews. Endocrinology. 2014; 10 (5): 261-275.
17. Guo SW,. An overview of the current status of clinical trials on endometriosis: issues and concerns. Fertil Steril. 2014; 101 (1): 183-190. e184.
18. Schwager K, Bootz F, Imesch P, Kaspar M, Trachsel E, Neri D,. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Hum Reprod. 2011; 26 (9): 2344-2352.
19. Villa A, Trachsel E, Kaspar M,. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Int J Cancer. 2008; 122 (11): 2405-2413.
20. Schwager K, Kaspar M, Bootz F,. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Res Ther. 2009; 11 (5): R142.
21. Rybak JN, Roesli C, Kaspar M, Villa A, Neri D,. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res. 2007; 67 (22): 10948-10957.
22. Schliemann C, Wiedmer A, Pedretti M, Szczepanowski M, Klapper W, Neri D,. Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma. Leukemia Res. 2009; 33 (12): 1718-1722.
23. Gutbrodt KL, Schliemann C, Giovannoni L,. Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia. Sci Transl Med. 2013; 5 (201): 201ra118.
24. Franz M, Hilger I, Grun K,. Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin. J Heart Lung Transplant. 2013; 32 (6): 641-650.
25. Fiechter M, Frey K, Fugmann T, Kaufmann PA, Neri D,. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. Atherosclerosis. 2011; 214 (2): 325-330.
26. Hemmerle T, Zgraggen S, Matasci M, Halin C, Detmar M, Neri D,. Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation. J Dermatol Sci. 2014; 76 (2): 96-103.
27. Paul WE,. What determines Th2 differentiation, in vitro and in vivo? Immunol Cell Biol. 2010; 88 (3): 236-239.
28. Hemmerle T, Doll F, Neri D,. Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. Proc Natl Acad Sci U S A. 2014; 111 (33): 12008-12012.
29. Hemmerle T, Neri D,. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer. Int J Cancer. 2014; 134 (2): 467-477.
30. Ricci AG, Olivares CN, Bilotas MA, Meresman GF, Baranao RI,. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis. Reprod Sci. 2011; 18 (7): 614-622.
31. Beste MT, Pfaffle-Doyle N, Prentice EA,. Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation. Sci Transl Med. 2014; 6 (222): 222ra216.
32. Efstathiou JA, Sampson DA, Levine Z,. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model. Fertil Steril. 2005; 83 (1): 171-181.
33. Mantovani A, Sica A, Locati M,. New vistas on macrophage differentiation and activation. Eur J Immunol. 2007; 37 (1): 14-16.
34. De Palma M, Naldini L,. Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? Biochimica et biophysica acta. 2009; 1796 (1): 5-10.
35. Capobianco A, Monno A, Cottone L,. Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. Am J Pathol. 2011; 179 (5): 2651-2659.
36. Garcia S, Krausz S, Ambarus CA,. Tie2 signaling cooperates with TNF to promote the pro-inflammatory activation of human macrophages independently of macrophage functional phenotype. PloS One. 2014; 9 (1): e82088.
37. Dunselman GA, Groothuis PG, de Goeij AF, Evers JL,. The Mesothelium, Teflon or Velcro? Mesothelium in endometriosis pathogenesis. Hum Reprod. 2001; 16 (4): 605-607.
38. Young VJ, Brown JK, Saunders PT, Horne AW,. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update. 2013; 19 (5): 558-569.
39. van der Linden PJ, de Goeij AF, Dunselman GA, van der Linden EP, Ramaekers FC, Evers JL,. Expression of integrins and E-cadherin in cells from menstrual effluent, endometrium, peritoneal fluid, peritoneum, and endometriosis. Fertil Steril. 1994; 61 (1): 85-90.
40. Hull ML, Escareno CR, Godsland JM,. Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol. 2008; 173 (3): 700-715.
41. Herzberg F, Schoning M, Schirner M, Topp M, Thiel E, Kreuser ED,. IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells. Clin Exp Metastasis. 1996; 14 (2): 165-175.
42. Gilabert-Estelles J, Ramon LA, Espana F,. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod. 2007; 22 (8): 2120-2127.
43. Sotnikova NY, Antsiferova YS, Posiseeva LV, Shishkov DN, Posiseev DV, Filippova ES,. Mechanisms regulating invasiveness and growth of endometriosis lesions in rat experimental model and in humans. Fertil Steril. 2010; 93 (8): 2701-2705.
44. Itoh H, Kishore AH, Lindqvist A, Rogers DE, Word RA,. Transforming growth factor beta1 (TGFbeta1) and progesterone regulate matrix metalloproteinases (MMP) in human endometrial stromal cells. J Clin Endocrinol Metab. 2012; 97 (6): E888-897.
45. Boettner B, Govek EE, Cross J, Van Aelst L,. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc Nat Acad Sci U S A. 2000; 97 (16): 9064-9069.
46. Frey K, Zivanovic A, Schwager K, Neri D,. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integr Biol. 2011; 3 (4): 468-478.
47. Ghoreschi K, Thomas P, Breit S,. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med. 2003; 9 (1): 40-46.